Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to $319.6 million.

  • Myriad Genetics' Other Operating Expenses fell 1.53% to $71.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $622.5 million, marking a year-over-year increase of 82.28%. This contributed to the annual value of $319.6 million for FY2024, which is 20.50% down from last year.
  • According to the latest figures from FY2024, Myriad Genetics' Other Operating Expenses is $319.6 million, which was down 20.50% from $402.0 million recorded in FY2023.
  • In the past 5 years, Myriad Genetics' Other Operating Expenses registered a high of $402.0 million during FY2023, and its lowest value of $199.4 million during FY2021.
  • Over the past 3 years, Myriad Genetics' median Other Operating Expenses value was $319.6 million (recorded in 2024), while the average stood at $335.1 million.
  • Per our database at Business Quant, Myriad Genetics' Other Operating Expenses surged by 1,971.01% in 2020 and then declined by 27.91% in 2021.
  • Yearly analysis of 5 years shows Myriad Genetics' Other Operating Expenses stood at $285.8 million in 2020, then reached $276.6 million in 2020, then declined by 27.91% to $199.4 million in 2021, then spiked by 42.28% to $283.7 million in 2022, then surged by 41.70% to $402.0 million in 2023, then decreased by 20.50% to $319.6 million in 2024.